Frederik M Nielsen, Thomas L Klitgaard, Martin Siegemund, Jon H Laake, Katrin M Thormar, Jade M Cole, Søren R Aagaard, Anne-Marie G Bunzel, Stine R Vestergaard, Peter K Langhoff, Caroline H Pedersen, Josefine Ø Hejlesen, Salim Abdelhamid, Anna Dietz, Caroline E Gebhard, Nuria Zellweger, Alexa Hollinger, Lone M Poulsen, Sarah Weihe, Nina C Andersen-Ranberg, Ulf G Pedersen, Ole Mathiesen, Anne Sofie Andreasen, Helene Brix, Jonas J Thomsen, Christina H Petersen, Morten H Bestle, Sine Wichmann, Martin S Lund, Karoline M Mortensen, Björn A Brand, Nicolai Haase, Susanne A Iversen, Klaus V Marcussen, Anne C Brøchner, Morten Borup, Thorbjørn Grøfte, Thomas Hildebrandt, Maj-Brit N Kjær, Janus Engstrøm, Theis Lange, Anders Perner, Olav L Schjørring, Bodil S Rasmussen
IMPORTANCE: Supplemental oxygen is ubiquitously used in patients with COVID-19 and severe hypoxemia, but a lower dose may be beneficial. OBJECTIVE: To assess the effects of targeting a Pao2 of 60 mm Hg vs 90 mm Hg in patients with COVID-19 and severe hypoxemia in the intensive care unit (ICU). DESIGN, SETTING, AND PARTICIPANTS: Multicenter randomized clinical trial including 726 adults with COVID-19 receiving at least 10 L/min of oxygen or mechanical ventilation in 11 ICUs in Europe from August 2020 to March 2023...
March 19, 2024: JAMA